RIGL vs TFX · P/E 9.1, rev $137.5M vs P/E 2083, rev $1.12B
Rigel Pharmaceuticals Inc (RIGL) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
RIGL currently screens at market cap $338.3M and trailing P/E 9.1. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the RIGL and TFX stock pages for the full models.
Not investment advice.